Polyphron
PrivateLast Round
Seed
Sep 17, 2026
Total Funding Raised
$20M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Polyphron is a biotechnology company that develops an autonomous tissue foundry to manufacture functional human tissue for regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Polyphron Comparables
Compare Polyphron with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cell X Technologies | 80% | |
| Trestle Biotherapeutics | 78% | |
| Somite AI | 74% |
Polyphron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 17, 2026 |
Polyphron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gradient Ventures | Seed |
| Atypical | Seed |
| Haystack | Seed |
| Loyal VC | Seed |
| R7 Partners | Seed |
| Humba Ventures | Seed |
| Boost VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
Grew 125% QoQ, from 4 to 9 employees.
- Sep 17, 2026
$20M round led by Quiet Capital
Recent news
Latest coverage and updates
- receives_financingSep 18, 2026
Polyphron, Inc. receives $20M in Seed financing led by Quiet Capital, with participation from Gradient, Haystack, and Compound, to build a verification layer for AI-driven biology in New York on Sep 18th '26.
Polyphron Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Polyphron's valuation, stock price, and market status.
Is Polyphron a public or private company?
Polyphron is a private company.
What is the current stock price of Polyphron?
Polyphron is a private company, so its shares have no public market price. Caplight tracks Polyphron's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Polyphron worth (valuation)?
Valuation information for Polyphron is not publicly available.
Can I buy Polyphron stock?
Polyphron shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Polyphron's last funding round?
Polyphron's most recent funding round was Seed on September 17, 2026.
Who are the main investors in Polyphron?
Key investors in Polyphron include Quiet Capital.
Will Polyphron IPO soon?
No public IPO plans have been announced for Polyphron.
How can I track Polyphron secondary market activity?
Caplight tracks bids, offers, and trades in Polyphron's shares on secondary markets.